The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...